DSM-Firmenich AG

dsm-firmenich repurchased 225,858 ordinary shares during the week of August 17 through August 21, 2026, at an average price of €88.45 per share for a total of €20.0 million. The buyback is part of a €540 million program announced on February 9, 2026, of which €40 million was earmarked to cover share-based compensation plans and €500 million to reduce issued capital. The €40 million compensation-related tranche was completed on March 23, 2026, while the €500 million capital-reduction portion is expected to finish by the end of the third quarter of 2026. To date, the company has repurchased 5,578,038 shares at an average price of €69.93, totaling €390.1 million.

dsm-firmenich repurchased 140,000 shares during the week of August 3 to August 7, 2026, at an average price of €93.18 per share for a total of €13.0 million. The buyback is part of a larger program announced on February 9, 2026, which includes a €40 million tranche to cover share-based compensation plans and a €500 million tranche to reduce issued capital. The €40 million tranche was completed on March 23, 2026, while the €500 million capital reduction tranche is expected to finish by the end of the third quarter of 2026. To date, the company has repurchased 5,212,680 shares at an average price of €68.53 for a total consideration of €357.2 million.

Origis Energy announced the start of commercial operations for three additional phases of its Rockhound Solar complex in Ector County, Texas, bringing total operating capacity at the site to nearly 1 GWdc. The newly completed phases represent roughly 500 MWdc of solar capacity, marking a major milestone in the buildout of one of the largest renewable energy infrastructure complexes in the country. Upon full completion, the Rockhound complex is expected to exceed 2 GW of solar and storage capacity by 2029, with long-term contracts already in place with Meta, Occidental, dsm-firmenich, and Bekaert. The next phase, representing approximately 1 GW of additional solar and storage capacity, is currently being marketed for data center co-location opportunities and long-term corporate offtake structures.

dsm-firmenich reported a 5% like-for-like sales increase in the first half of 2026, with second-quarter growth accelerating to 6%. Adjusted EBITDA reached €900 million, and the company confirmed its full-year outlook, expecting like-for-like sales growth at the higher end of its 2-to-4% target range and an adjusted EBITDA margin of around 20%. Core adjusted earnings per share rose 14% to €1.84. The company also highlighted progress on its 2026-2028 action plan, a successful dual listing on the SIX Swiss Exchange in May, and a €500 million share buyback program that was about 62% complete as of late July.

dsm-firmenich repurchased 152,262 ordinary shares during the week of July 20 through July 24, 2026, at an average price of €83.61 per share for a total of €12.7 million. The buyback is part of a larger program announced on February 9, 2026, which includes a €40 million tranche to cover share-based compensation plans—already completed on March 23, 2026—and a €500 million tranche to reduce issued capital, expected to finish by the end of the third quarter of 2026. To date, the company has bought back 4,972,593 shares under the overall program at an average price of €67.53, totaling €335.8 million.

dsm-firmenich reported that it repurchased 149,913 shares during the week of July 13 through July 17, 2026, at an average price of €84.92 per share for a total of €12.7 million. The buyback is part of a larger program announced on February 9, 2026, which includes a €40 million tranche to cover share-based compensation plans—already completed on March 23, 2026—and a €500 million tranche to reduce issued capital, expected to finish by the end of the third quarter of 2026. Since the program began on March 12, 2026, the company has repurchased 4,820,331 shares at an average price of €67.03, totaling €323.1 million.

The global encapsulated essential oils for feed market is projected to grow from an estimated $1.18 billion in 2026 to $1.67 billion by 2030, at a compound annual growth rate of 9.1%, according to a new report from ResearchAndMarkets.com. The report covers 16 countries and eight regions, analyzing product types including microencapsulated, nanoencapsulated, and macroencapsulated forms, with detailed subsegment breakdowns such as spray-dried microcapsules, nanoemulsions, and extruded capsules. Key companies profiled include Cargill Incorporated, Archer-Daniels-Midland Company, DSM-Firmenich AG, International Flavors & Fragrances Inc., and Symrise AG. The study highlights drivers such as the shift toward antibiotic-free livestock production, adoption of natural feed additives for gut health, and demand for controlled-release encapsulation technologies. Expanded geographic coverage includes Taiwan and Southeast Asia, reflecting ongoing manufacturing shifts and supply chain realignments.

dsm-firmenich repurchased 150,000 shares during the week of July 6 to July 10, 2026, at an average price of €84.43 per share for a total of €12.7 million. This is part of a €500 million share repurchase program to reduce issued capital, which began on March 12, 2026, alongside a separate €40 million buyback for share-based compensation plans that was completed on March 23, 2026. To date, the company has bought back 4,670,418 shares under the combined programs at an average price of €66.45 for a total consideration of €310.4 million. The €500 million capital reduction program is expected to be completed by the end of the third quarter of 2026.

dsm-firmenich repurchased 155,456 shares between June 29 and July 3, 2026, at an average price of €82.45 per share for a total of €12.8 million. The buyback is part of a €500 million share repurchase program to reduce issued capital, which began on March 12, 2026, alongside a separate €40 million tranche to cover share-based compensation plans that was completed on March 23, 2026. To date, the company has bought back 4,520,418 shares at an average price of €65.86 for a total consideration of €297.7 million. The €500 million capital reduction program is expected to be completed by the end of the third quarter of 2026.